Table 2.
The experimentally determined and estimated stereoselectivities (α) for the chiral compounds used in this study
| Compound | α (Exp) | α (Est) |
|---|---|---|
| (R,S)-verapamil | 77 | 150 |
| (R,S)-atenolol | 0.5 | 0.8 |
| (R,S)-propranolol | 3.0 | 1.4 |
| (RR,SS)-pseudoephedrine | 1.5 | 1.8 |
| (RR,SS)-fenoterol | 0.3 | 0.4 |
| (RS,SR)-fenoterol | 0.5 | 0.7 |
| (R,S)-isoproterenol | 1.5 | 1.4 |
| (R,S)-disopyramide | 2.0 | 1.2 |
| Quinine/quinidine | 1.6 | 1.5 |
| (R,S)/(R,R)-fenoterol | 1.1 | 1.2 |
| (S,R)/(R,R)-fenoterol | 0.5 | 0.9 |
| (R,S)/(S,S)-fenoterol | 3.5 | 2.8 |
| (S,R)/(S,S)-fenoterol | 1.7 | 2.1 |
For the enantiomeric pairs, the α value is defined as Ki(S)/Ki(R), and for the diastereomeric pairs, the ratios are as presented in the table.